Reported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| STEPAN COSCL · Entity 4733 | Director · President & CEO | March 08, 2024 | March 11, 2024 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
STEPAN CO
Report date March 08, 2024 · Filed March 11, 2024
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 14,418.404 |
Reported balance
After 2024-03-08 transaction · row 1
1 source rowRow 1 · 2024-03-08 · Tax withholding · Disposed 647 · Balance 14,418.404 F1: The transaction reported reflects the withholding of shares from the performance shares vested on February 15, 2024. Withholding of these shares was applied to the reporting person's account on the transaction date shown. |
Filing footnotes · ownership attribution and instrument terms
F1: The transaction reported reflects the withholding of shares from the performance shares vested on February 15, 2024. Withholding of these shares was applied to the reporting person's account on the transaction date shown.
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| February 17, 2021 Filed Feb 19, 2021 22:00 UTC | STEPAN CO SCL · Entity 4733 | GrantStock Appreciation Right · Derivative | 12,332 | $0.00 Strike: $123.73 | $0.00 |
DisclosureSEC source: 0001127602-21-006816 · form4.xml · derivative · entry 4 Behrens Scott R. · CIK 0001616912 · VP/GM Surfactants 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 12,332 Underlying: Common Stock · 12,332 shares Expires 2031-02-16 F2 · derivative.exercise_date: Vests ratably over three years beginning on the date shown. Read SEC document |
| February 17, 2021 Filed Feb 19, 2021 22:00 UTC | STEPAN CO SCL · Entity 4733 | GrantStock Option (Right to Buy) · Derivative | 4,111 | $0.00 Strike: $123.73 | $0.00 |
DisclosureSEC source: 0001127602-21-006816 · form4.xml · derivative · entry 3 Behrens Scott R. · CIK 0001616912 · VP/GM Surfactants 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 4,111 Underlying: Common Stock · 4,111 shares Expires 2031-02-16 F2 · derivative.exercise_date: Vests ratably over three years beginning on the date shown. Read SEC document |
| February 17, 2021 Filed Feb 19, 2021 22:00 UTC | STEPAN CO SCL · Entity 4733 | GrantCommon Stock | 73.968 | $123.65 | $9,146.14 |
DisclosureSEC source: 0001127602-21-006816 · form4.xml · nonDerivative · entry 2 Behrens Scott R. · CIK 0001616912 · VP/GM Surfactants 10b5-1 filing: Not disclosed Ownership: Indirect · By Esop II Trust Disclosed balance after: 3,826.882 Read SEC document |
| February 17, 2021 Filed Feb 19, 2021 22:00 UTC | STEPAN CO SCL · Entity 4733 | Exercise / conversionCommon Stock | 2,383 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001127602-21-006816 · form4.xml · nonDerivative · entry 1 Behrens Scott R. · CIK 0001616912 · VP/GM Surfactants 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 13,609.888 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: The performance shares vested upon Stepan Company achieving certain financial targets by December 31, 2020. Read SEC document |
| December 15, 2020 Filed Dec 17, 2020 20:24 UTC | STEPAN CO SCL · Entity 4733 | GrantShare Units · Derivative | 23.071 | $119.43 | $2,755.37 |
DisclosureSEC source: 0001127602-20-031767 · form4.xml · derivative · entry 3 Behrens Scott R. · CIK 0001616912 · VP/GM Surfactants 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 9,057.007 Underlying: Common Stock · 23.071 shares Expires not disclosed F3 · security: Share Units are acquired under the Management Incentive Plan (As Amended and Restated Effective January 1, 2015) ("MIP"), a nonqualified deferred compensation plan which allows MIP participants to elect to defer all or a portion of their deferred compensation into accounts pursuant to MIP provisions. F4 · derivative.exercise_price: Share Units convert on a one-for-one basis into Common Stock. F6 · price: Price reported is the price of Common Stock on the date the dividend equivalents are payable pursuant to a dividend equivalent feature of the MIP. F5 · derivative.exercise_date: Reflects acquisition of Share Units pursuant to a dividend equivalent feature of the MIP, generally payable at end of employment, unless otherwise elected. F5 · derivative.expiration_date: Reflects acquisition of Share Units pursuant to a dividend equivalent feature of the MIP, generally payable at end of employment, unless otherwise elected. Read SEC document |
| December 15, 2020 Filed Dec 17, 2020 20:24 UTC | STEPAN CO SCL · Entity 4733 | GrantCommon Stock | 26.691 | $119.43 | $3,187.71 |
DisclosureSEC source: 0001127602-20-031767 · form4.xml · nonDerivative · entry 1 Behrens Scott R. · CIK 0001616912 · VP/GM Surfactants 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 11,226.888 F1 · kind: Reflects acquisition of deferred share units under the Performance Award Deferred Compensation Plan ("Plan") pursuant to a dividend equivalent feature of the Plan. Read SEC document |
| September 15, 2020 Filed Sep 17, 2020 21:39 UTC | STEPAN CO SCL · Entity 4733 | GrantShare Units · Derivative | 21.308 | $116.32 | $2,478.55 |
DisclosureSEC source: 0001127602-20-025329 · form4.xml · derivative · entry 3 Behrens Scott R. · CIK 0001616912 · VP/GM Surfactants 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 9,033.936 Underlying: Common Stock · 21.308 shares Expires not disclosed F3 · security: Share Units are acquired under the Management Incentive Plan (As Amended and Restated Effective January 1, 2015) ("MIP"), a nonqualified deferred compensation plan which allows MIP participants to elect to defer all or a portion of their deferred compensation into accounts pursuant to MIP provisions. F4 · derivative.exercise_price: Share Units convert on a one-for-one basis into Common Stock. F6 · price: Price reported is the price of Common Stock on the date the dividend equivalents are payable pursuant to a dividend equivalent feature of the MIP. F5 · derivative.exercise_date: Reflects acquisition of Share Units pursuant to a dividend equivalent feature of the MIP, generally payable at end of employment, unless otherwise elected. F5 · derivative.expiration_date: Reflects acquisition of Share Units pursuant to a dividend equivalent feature of the MIP, generally payable at end of employment, unless otherwise elected. Read SEC document |
| September 15, 2020 Filed Sep 17, 2020 21:39 UTC | STEPAN CO SCL · Entity 4733 | GrantCommon Stock | 24.651 | $116.32 | $2,867.40 |
DisclosureSEC source: 0001127602-20-025329 · form4.xml · nonDerivative · entry 1 Behrens Scott R. · CIK 0001616912 · VP/GM Surfactants 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 11,200.197 F1 · kind: Reflects acquisition of deferred share units under the Performance Award Deferred Compensation Plan ("Plan") pursuant to a dividend equivalent feature of the Plan. Read SEC document |
| August 18, 2020 Filed Aug 19, 2020 18:23 UTC | STEPAN CO SCL · Entity 4733 | SaleCommon Stock | 1,816 | $117.08 | $212,617.28 |
DisclosureSEC source: 0001127602-20-023885 · form4.xml · nonDerivative · entry 11 Behrens Scott R. · CIK 0001616912 · VP/GM Surfactants 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 11,175.546 Read SEC document |
| August 17, 2020 Filed Aug 19, 2020 18:23 UTC | STEPAN CO SCL · Entity 4733 | Exercise / conversionStock Appreciation Right · Derivative | 6,893 | $0.00 Strike: $72.99 | $0.00 |
DisclosureSEC source: 0001127602-20-023885 · form4.xml · derivative · entry 17 Behrens Scott R. · CIK 0001616912 · VP/GM Surfactants 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,447 Underlying: Common Stock · 6,893 shares Expires 2028-02-20 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| August 17, 2020 Filed Aug 19, 2020 18:23 UTC | STEPAN CO SCL · Entity 4733 | Exercise / conversionEmployee Stock Option (Right to Buy) · Derivative | 1,665 | $0.00 Strike: $58.22 | $0.00 |
DisclosureSEC source: 0001127602-20-023885 · form4.xml · derivative · entry 16 Behrens Scott R. · CIK 0001616912 · VP/GM Surfactants 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 1,665 shares Expires 2024-04-28 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| August 17, 2020 Filed Aug 19, 2020 18:23 UTC | STEPAN CO SCL · Entity 4733 | Exercise / conversionEmployee Stock Option (Right to Buy) · Derivative | 4,087 | $0.00 Strike: $43.85 | $0.00 |
DisclosureSEC source: 0001127602-20-023885 · form4.xml · derivative · entry 15 Behrens Scott R. · CIK 0001616912 · VP/GM Surfactants 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 4,087 shares Expires 2026-02-22 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| August 17, 2020 Filed Aug 19, 2020 18:23 UTC | STEPAN CO SCL · Entity 4733 | Exercise / conversionEmployee Stock Option (Right to Buy) · Derivative | 787 | $0.00 Strike: $61.91 | $0.00 |
DisclosureSEC source: 0001127602-20-023885 · form4.xml · derivative · entry 14 Behrens Scott R. · CIK 0001616912 · VP/GM Surfactants 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 787 shares Expires 2024-02-17 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| August 17, 2020 Filed Aug 19, 2020 18:23 UTC | STEPAN CO SCL · Entity 4733 | Exercise / conversionEmployee Stock Option (Right to Buy) · Derivative | 777 | $0.00 Strike: $63.11 | $0.00 |
DisclosureSEC source: 0001127602-20-023885 · form4.xml · derivative · entry 13 Behrens Scott R. · CIK 0001616912 · VP/GM Surfactants 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 777 shares Expires 2023-02-18 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| August 17, 2020 Filed Aug 19, 2020 18:23 UTC | STEPAN CO SCL · Entity 4733 | SaleCommon Stock | 1,216 | $118.55 | $144,151.94 |
DisclosureSEC source: 0001127602-20-023885 · form4.xml · nonDerivative · entry 10 Behrens Scott R. · CIK 0001616912 · VP/GM Surfactants 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 12,991.546 F6 · price: The price reported is a weighted average price. Shares were sold in a series of transactions within the same trading day at prices ranging from $118.49 to $118.80, inclusive. Full information regarding the number of shares sold at each separate price is available upon request by the Commission staff, the issuer, or a security holder of the issuer. Read SEC document |
| August 17, 2020 Filed Aug 19, 2020 18:23 UTC | STEPAN CO SCL · Entity 4733 | SaleCommon Stock | 4,630 | $117.75 | $545,191.76 |
DisclosureSEC source: 0001127602-20-023885 · form4.xml · nonDerivative · entry 9 Behrens Scott R. · CIK 0001616912 · VP/GM Surfactants 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 14,207.546 F5 · price: The price reported is a weighted average price. Shares were sold in a series of transactions within the same trading day at prices ranging from $117.39 to $118.355, inclusive. Full information regarding the number of shares sold at each separate price is available upon request by the Commission staff, the issuer, or a security holder of the issuer. Read SEC document |
| August 17, 2020 Filed Aug 19, 2020 18:23 UTC | STEPAN CO SCL · Entity 4733 | SaleCommon Stock | 1,470 | $117.09 | $172,119.36 |
DisclosureSEC source: 0001127602-20-023885 · form4.xml · nonDerivative · entry 8 Behrens Scott R. · CIK 0001616912 · VP/GM Surfactants 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 18,837.546 F4 · price: The price reported is a weighted average price. Shares were sold in a series of transactions within the same trading day at prices ranging from $116.30 to $117.265, inclusive. Full information regarding the number of shares sold at each separate price is available upon request by the Commission staff, the issuer, or a security holder of the issuer. Read SEC document |
| August 17, 2020 Filed Aug 19, 2020 18:23 UTC | STEPAN CO SCL · Entity 4733 | Tax withholdingCommon Stock | 753 | $116.35 | $87,611.55 |
DisclosureSEC source: 0001127602-20-023885 · form4.xml · nonDerivative · entry 7 Behrens Scott R. · CIK 0001616912 · VP/GM Surfactants 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 20,307.546 F3 · kind: Withholding of shares to satisfy tax liability on exercise of SARs. Read SEC document |
| August 17, 2020 Filed Aug 19, 2020 18:23 UTC | STEPAN CO SCL · Entity 4733 | Disposition to issuerCommon Stock | 4,324 | $116.35 | $503,097.40 |
DisclosureSEC source: 0001127602-20-023885 · form4.xml · nonDerivative · entry 6 Behrens Scott R. · CIK 0001616912 · VP/GM Surfactants 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 21,060.546 F2 · kind: Deemed disposition of underlying common stock to the issuer in an amount equal to the conversion price of the SARs. Read SEC document |
| August 17, 2020 Filed Aug 19, 2020 18:23 UTC | STEPAN CO SCL · Entity 4733 | Exercise / conversionCommon Stock | 6,893 | $72.99 | $503,120.07 |
DisclosureSEC source: 0001127602-20-023885 · form4.xml · nonDerivative · entry 5 Behrens Scott R. · CIK 0001616912 · VP/GM Surfactants 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 25,384.546 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: The Stock Appreciation Rights ("SARs") were settled in shares of common stock as per the terms of the award. Read SEC document |
| August 17, 2020 Filed Aug 19, 2020 18:23 UTC | STEPAN CO SCL · Entity 4733 | Exercise / conversionCommon Stock | 1,665 | $58.22 | $96,936.30 |
DisclosureSEC source: 0001127602-20-023885 · form4.xml · nonDerivative · entry 4 Behrens Scott R. · CIK 0001616912 · VP/GM Surfactants 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 18,491.546 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| August 17, 2020 Filed Aug 19, 2020 18:23 UTC | STEPAN CO SCL · Entity 4733 | Exercise / conversionCommon Stock | 4,087 | $43.85 | $179,214.95 |
DisclosureSEC source: 0001127602-20-023885 · form4.xml · nonDerivative · entry 3 Behrens Scott R. · CIK 0001616912 · VP/GM Surfactants 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 16,826.546 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| August 17, 2020 Filed Aug 19, 2020 18:23 UTC | STEPAN CO SCL · Entity 4733 | Exercise / conversionCommon Stock | 787 | $61.91 | $48,723.17 |
DisclosureSEC source: 0001127602-20-023885 · form4.xml · nonDerivative · entry 2 Behrens Scott R. · CIK 0001616912 · VP/GM Surfactants 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 12,739.546 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| August 17, 2020 Filed Aug 19, 2020 18:23 UTC | STEPAN CO SCL · Entity 4733 | Exercise / conversionCommon Stock | 777 | $63.11 | $49,036.47 |
DisclosureSEC source: 0001127602-20-023885 · form4.xml · nonDerivative · entry 1 Behrens Scott R. · CIK 0001616912 · VP/GM Surfactants 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 11,952.546 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| July 31, 2020 Filed Aug 4, 2020 00:07 UTC | STEPAN CO SCL · Entity 4733 | Exercise / conversionStock Appreciation Right · Derivative | 9,494 | $0.00 Strike: $78.58 | $0.00 |
DisclosureSEC source: 0001127602-20-022630 · form4.xml · derivative · entry 7 Behrens Scott R. · CIK 0001616912 · VP/GM Surfactants 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 9,494 shares Expires 2027-02-20 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| July 31, 2020 Filed Aug 4, 2020 00:07 UTC | STEPAN CO SCL · Entity 4733 | SaleCommon Stock | 261 | $109.33 | $28,535.65 |
DisclosureSEC source: 0001127602-20-022630 · form4.xml · nonDerivative · entry 5 Behrens Scott R. · CIK 0001616912 · VP/GM Surfactants 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 11,175.546 F5 · price: The price reported is a weighted average price. Shares were sold in a series of transactions within the same trading day at prices ranging from $109.29 to $109.42, inclusive. Full information regarding the number of shares sold at each separate price is available upon request by the Commission staff, the issuer, or a security holder of the issuer. Read SEC document |
| July 31, 2020 Filed Aug 4, 2020 00:07 UTC | STEPAN CO SCL · Entity 4733 | SaleCommon Stock | 1,552 | $108.04 | $167,682.74 |
DisclosureSEC source: 0001127602-20-022630 · form4.xml · nonDerivative · entry 4 Behrens Scott R. · CIK 0001616912 · VP/GM Surfactants 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 11,436.546 F4 · price: The price reported is a weighted average price. Shares were sold in a series of transactions within the same trading day at prices ranging from $107.585 to $108.57, inclusive. Full information regarding the number of shares sold at each separate price is available upon request by the Commission staff, the issuer, or a security holder of the issuer. Read SEC document |
| July 31, 2020 Filed Aug 4, 2020 00:07 UTC | STEPAN CO SCL · Entity 4733 | Tax withholdingCommon Stock | 751 | $107.66 | $80,852.66 |
DisclosureSEC source: 0001127602-20-022630 · form4.xml · nonDerivative · entry 3 Behrens Scott R. · CIK 0001616912 · VP/GM Surfactants 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 12,988.546 F3 · kind: Withholding of shares to satisfy tax liability on exercise of SARs. Read SEC document |
| July 31, 2020 Filed Aug 4, 2020 00:07 UTC | STEPAN CO SCL · Entity 4733 | Disposition to issuerCommon Stock | 6,930 | $107.66 | $746,083.80 |
DisclosureSEC source: 0001127602-20-022630 · form4.xml · nonDerivative · entry 2 Behrens Scott R. · CIK 0001616912 · VP/GM Surfactants 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 13,739.546 F2 · kind: Deemed disposition of underlying common stock to the issuer in an amount equal to the conversion price of the SARs. Read SEC document |
| July 31, 2020 Filed Aug 4, 2020 00:07 UTC | STEPAN CO SCL · Entity 4733 | Exercise / conversionCommon Stock | 9,494 | $78.58 | $746,038.52 |
DisclosureSEC source: 0001127602-20-022630 · form4.xml · nonDerivative · entry 1 Behrens Scott R. · CIK 0001616912 · VP/GM Surfactants 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 20,669.546 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: The Stock Appreciation Rights ("SARs") were settled in shares of common stock as per the terms of the award. Read SEC document |
| July 27, 2020 Filed Jul 29, 2020 17:50 UTC | STEPAN CO SCL · Entity 4733 | SaleCommon Stock | 445 | $109.02 | $48,514.17 |
DisclosureSEC source: 0001127602-20-022201 · form4.xml · nonDerivative · entry 1 Behrens Scott R. · CIK 0001616912 · VP/GM Surfactants 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 11,175.546 F1 · price: The price reported is a weighted average price. Shares were sold in a series of transactions within the same trading day at prices ranging from $109.00 to $109.120, inclusive. Full information regarding the number of shares sold at each separate price is available upon request by the Commission staff, the issuer, or a security holder of the issuer. Read SEC document |
| June 15, 2020 Filed Jun 17, 2020 15:56 UTC | STEPAN CO SCL · Entity 4733 | GrantShare Units · Derivative | 25.723 | $96.08 | $2,471.47 |
DisclosureSEC source: 0001127602-20-019841 · form4.xml · derivative · entry 5 Behrens Scott R. · CIK 0001616912 · VP/GM Surfactants 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 9,012.628 Underlying: Common Stock · 25.723 shares Expires not disclosed F3 · security: Share Units are acquired under the Management Incentive Plan (As Amended and Restated Effective January 1, 2015) ("MIP"), a nonqualified deferred compensation plan which allows MIP participants to elect to defer all or a portion of their deferred compensation into accounts pursuant to MIP provisions. F4 · derivative.exercise_price: Share Units convert on a one-for-one basis into Common Stock. F6 · price: Price reported is the price of Common Stock on the date the dividend equivalents are payable pursuant to a dividend equivalent feature of the MIP. F5 · derivative.exercise_date: Reflects acquisition of Share Units pursuant to a dividend equivalent feature of the MIP, generally payable at end of employment, unless otherwise elected. F5 · derivative.expiration_date: Reflects acquisition of Share Units pursuant to a dividend equivalent feature of the MIP, generally payable at end of employment, unless otherwise elected. Read SEC document |
| June 15, 2020 Filed Jun 17, 2020 15:56 UTC | STEPAN CO SCL · Entity 4733 | GrantCommon Stock | 29.759 | $96.08 | $2,859.24 |
DisclosureSEC source: 0001127602-20-019841 · form4.xml · nonDerivative · entry 2 Behrens Scott R. · CIK 0001616912 · VP/GM Surfactants 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 11,620.546 F1 · kind: Reflects acquisition of deferred share units under the Performance Award Deferred Compensation Plan ("Plan") pursuant to a dividend equivalent feature of the Plan. Read SEC document |
| March 17, 2020 Filed Mar 18, 2020 17:35 UTC | STEPAN CO SCL · Entity 4733 | SaleCommon Stock | 227 | $100.25 | $22,756.73 |
DisclosureSEC source: 0001127602-20-011201 · form4.xml · nonDerivative · entry 3 Behrens Scott R. · CIK 0001616912 · VP/GM Surfactants 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 11,556.448 F3 · price: The price reported is a weighted average price. Shares were sold in a series of transactions within the same trading day at prices ranging from $100.120 to $100.360, inclusive. Full information regarding the number of shares sold at each separate price is available upon request by the Commission staff, the issuer, or a security holder of the issuer. Read SEC document |
| March 17, 2020 Filed Mar 18, 2020 17:35 UTC | STEPAN CO SCL · Entity 4733 | SaleCommon Stock | 200 | $98.75 | $19,750.50 |
DisclosureSEC source: 0001127602-20-011201 · form4.xml · nonDerivative · entry 2 Behrens Scott R. · CIK 0001616912 · VP/GM Surfactants 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 11,783.448 F2 · price: The price reported is a weighted average price. Shares were sold in a series of transactions within the same trading day at prices ranging from $98.500 to $99.010, inclusive. Full information regarding the number of shares sold at each separate price is available upon request by the Commission staff, the issuer, or a security holder of the issuer. Read SEC document |
| March 17, 2020 Filed Mar 18, 2020 17:35 UTC | STEPAN CO SCL · Entity 4733 | SaleCommon Stock | 573 | $97.84 | $56,063.70 |
DisclosureSEC source: 0001127602-20-011201 · form4.xml · nonDerivative · entry 1 Behrens Scott R. · CIK 0001616912 · VP/GM Surfactants 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 11,983.448 F1 · price: The price reported is a weighted average price. Shares were sold in a series of transactions within the same trading day at prices ranging from $97.490 to $98.460, inclusive. Full information regarding the number of shares sold at each separate price is available upon request by the Commission staff, the issuer, or a security holder of the issuer. Read SEC document |
| March 13, 2020 Filed Jun 17, 2020 15:56 UTC | STEPAN CO SCL · Entity 4733 | GrantShare Units · Derivative | 29.681 | $82.99 | $2,463.23 |
DisclosureSEC source: 0001127602-20-019841 · form4.xml · derivative · entry 4 Behrens Scott R. · CIK 0001616912 · VP/GM Surfactants 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 8,986.905 Underlying: Common Stock · 29.681 shares Expires not disclosed F3 · security: Share Units are acquired under the Management Incentive Plan (As Amended and Restated Effective January 1, 2015) ("MIP"), a nonqualified deferred compensation plan which allows MIP participants to elect to defer all or a portion of their deferred compensation into accounts pursuant to MIP provisions. F4 · derivative.exercise_price: Share Units convert on a one-for-one basis into Common Stock. F6 · price: Price reported is the price of Common Stock on the date the dividend equivalents are payable pursuant to a dividend equivalent feature of the MIP. F5 · derivative.exercise_date: Reflects acquisition of Share Units pursuant to a dividend equivalent feature of the MIP, generally payable at end of employment, unless otherwise elected. F5 · derivative.expiration_date: Reflects acquisition of Share Units pursuant to a dividend equivalent feature of the MIP, generally payable at end of employment, unless otherwise elected. Read SEC document |
| March 13, 2020 Filed Jun 17, 2020 15:56 UTC | STEPAN CO SCL · Entity 4733 | GrantCommon Stock | 34.339 | $82.99 | $2,849.79 |
DisclosureSEC source: 0001127602-20-019841 · form4.xml · nonDerivative · entry 1 Behrens Scott R. · CIK 0001616912 · VP/GM Surfactants 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 12,590.787 F1 · kind: Reflects acquisition of deferred share units under the Performance Award Deferred Compensation Plan ("Plan") pursuant to a dividend equivalent feature of the Plan. Read SEC document |
| March 03, 2020 Filed Mar 5, 2020 19:59 UTC | STEPAN CO SCL · Entity 4733 | Tax withholdingCommon Stock | 599 | $89.55 | $53,640.45 |
DisclosureSEC source: 0001127602-20-009587 · form4.xml · nonDerivative · entry 1 Behrens Scott R. · CIK 0001616912 · VP/GM Surfactants 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 12,556.448 F1 · kind: The transaction reported reflects the withholding of shares from the performance shares vested on February 19, 2020, which were reported on the Form 4 filed for the reporting person on February 21, 2020. Withholding of these shares were applied to the reporting person's account on the transaction date shown. Read SEC document |
| February 24, 2020 Filed Feb 27, 2020 00:28 UTC | STEPAN CO SCL · Entity 4733 | GrantCommon Stock | 79.562 | $98.37 | $7,826.51 |
DisclosureSEC source: 0001127602-20-008029 · form4.xml · nonDerivative · entry 1 Behrens Scott R. · CIK 0001616912 · VP/GM Surfactants 10b5-1 filing: Not disclosed Ownership: Indirect · By Esop II Trust Disclosed balance after: 3,710.733 Read SEC document |
| February 19, 2020 Filed Feb 21, 2020 19:59 UTC | STEPAN CO SCL · Entity 4733 | Exercise / conversionPerformance Shares · Derivative | 2,545 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001127602-20-006890 · form4.xml · derivative · entry 5 Behrens Scott R. · CIK 0001616912 · VP/GM Surfactants 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 2,545 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F4 · derivative.exercise_price: Each performance share represents a contingent right to receive 1 share of Stepan Company Common Stock. The performance shares vest upon Stepan Company achieving certain financial targets by December 31, 2019. F1 · price: The performance shares vested upon Stepan Company achieving certain financial targets by December 31, 2019. F4 · derivative.exercise_date: Each performance share represents a contingent right to receive 1 share of Stepan Company Common Stock. The performance shares vest upon Stepan Company achieving certain financial targets by December 31, 2019. F4 · derivative.expiration_date: Each performance share represents a contingent right to receive 1 share of Stepan Company Common Stock. The performance shares vest upon Stepan Company achieving certain financial targets by December 31, 2019. Read SEC document |
| February 19, 2020 Filed Feb 21, 2020 19:59 UTC | STEPAN CO SCL · Entity 4733 | GrantPerformance Shares · Derivative | 2,346 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001127602-20-006890 · form4.xml · derivative · entry 4 Behrens Scott R. · CIK 0001616912 · VP/GM Surfactants 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,346 Underlying: Common Stock · 2,346 shares Expires not disclosed F3 · derivative.exercise_price: Each performance share represents a contingent right to receive 1 share of Stepan Company Stock. The performance shares vest upon Stepan Company achieving certain financial targets by December 31, 2022. F3 · price: Each performance share represents a contingent right to receive 1 share of Stepan Company Stock. The performance shares vest upon Stepan Company achieving certain financial targets by December 31, 2022. F3 · derivative.exercise_date: Each performance share represents a contingent right to receive 1 share of Stepan Company Stock. The performance shares vest upon Stepan Company achieving certain financial targets by December 31, 2022. F3 · derivative.expiration_date: Each performance share represents a contingent right to receive 1 share of Stepan Company Stock. The performance shares vest upon Stepan Company achieving certain financial targets by December 31, 2022. Read SEC document |
| February 19, 2020 Filed Feb 21, 2020 19:59 UTC | STEPAN CO SCL · Entity 4733 | GrantStock Appreciation Right · Derivative | 10,413 | $0.00 Strike: $102.30 | $0.00 |
DisclosureSEC source: 0001127602-20-006890 · form4.xml · derivative · entry 3 Behrens Scott R. · CIK 0001616912 · VP/GM Surfactants 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 10,413 Underlying: Common Stock · 10,413 shares Expires 2030-02-18 F2 · derivative.exercise_date: Vests ratably over three years beginning on the date shown. Read SEC document |
| February 19, 2020 Filed Feb 21, 2020 19:59 UTC | STEPAN CO SCL · Entity 4733 | GrantStock Option (Right to Buy) · Derivative | 3,471 | $0.00 Strike: $102.30 | $0.00 |
DisclosureSEC source: 0001127602-20-006890 · form4.xml · derivative · entry 2 Behrens Scott R. · CIK 0001616912 · VP/GM Surfactants 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,471 Underlying: Common Stock · 3,471 shares Expires 2030-02-18 F2 · derivative.exercise_date: Vests ratably over three years beginning on the date shown. Read SEC document |
| February 19, 2020 Filed Feb 21, 2020 19:59 UTC | STEPAN CO SCL · Entity 4733 | Exercise / conversionCommon Stock | 2,043.635 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001127602-20-006890 · form4.xml · nonDerivative · entry 1 Behrens Scott R. · CIK 0001616912 · VP/GM Surfactants 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 13,155.448 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: The performance shares vested upon Stepan Company achieving certain financial targets by December 31, 2019. Read SEC document |
| December 13, 2019 Filed Dec 17, 2019 18:08 UTC | STEPAN CO SCL · Entity 4733 | GrantShare Units · Derivative | 24.93 | $98.53 | $2,456.35 |
DisclosureSEC source: 0001127602-19-035146 · form4.xml · derivative · entry 3 Behrens Scott R. · CIK 0001616912 · VP/GM Surfactants 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 8,957.224 Underlying: Common Stock · 24.93 shares Expires not disclosed F3 · security: Share Units are acquired under the Management Incentive Plan (As Amended and Restated Effective January 1, 2015) ("MIP"), a nonqualified deferred compensation plan which allows MIP participants to elect to defer all or a portion of their deferred compensation into accounts pursuant to MIP provisions. F4 · derivative.exercise_price: Share Units convert on a one-for-one basis into Common Stock. F6 · price: Price reported is the price of Common Stock on the date the dividend equivalents are payable pursuant to a dividend equivalent feature of the MIP. F5 · derivative.exercise_date: Reflects acquisition of Share Units pursuant to a dividend equivalent feature of the MIP, generally payable at end of employment, unless otherwise elected. F5 · derivative.expiration_date: Reflects acquisition of Share Units pursuant to a dividend equivalent feature of the MIP, generally payable at end of employment, unless otherwise elected. Read SEC document |
| December 13, 2019 Filed Dec 17, 2019 18:08 UTC | STEPAN CO SCL · Entity 4733 | GrantCommon Stock | 28.843 | $98.53 | $2,841.90 |
DisclosureSEC source: 0001127602-19-035146 · form4.xml · nonDerivative · entry 1 Behrens Scott R. · CIK 0001616912 · VP/GM Surfactants 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 11,111.813 F1 · kind: Reflects acquisition of deferred share units under the Performance Award Deferred Compensation Plan ("Plan") pursuant to a dividend equivalent feature of the Plan. Read SEC document |
| September 13, 2019 Filed Sep 17, 2019 18:26 UTC | STEPAN CO SCL · Entity 4733 | GrantShare Units · Derivative | 22.523 | $98.90 | $2,227.52 |
DisclosureSEC source: 0001127602-19-028551 · form4.xml · derivative · entry 3 Behrens Scott R. · CIK 0001616912 · VP/GM Surfactants 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 8,932.294 Underlying: Common Stock · 22.523 shares Expires not disclosed F3 · security: Share Units are acquired under the Management Incentive Plan (As Amended and Restated Effective January 1, 2015) ("MIP"), a nonqualified deferred compensation plan which allows MIP participants to elect to defer all or a portion of their deferred compensation into accounts pursuant to MIP provisions. F4 · derivative.exercise_price: Share Units convert on a one-for-one basis into Common Stock. F6 · price: Price reported is the price of Common Stock on the date the dividend equivalents are payable pursuant to a dividend equivalent feature of the MIP. F5 · derivative.exercise_date: Reflects acquisition of Share Units pursuant to a dividend equivalent feature of the MIP, generally payable at end of employment, unless otherwise elected. F5 · derivative.expiration_date: Reflects acquisition of Share Units pursuant to a dividend equivalent feature of the MIP, generally payable at end of employment, unless otherwise elected. Read SEC document |
| September 13, 2019 Filed Sep 17, 2019 18:26 UTC | STEPAN CO SCL · Entity 4733 | GrantCommon Stock | 26.057 | $98.90 | $2,577.04 |
DisclosureSEC source: 0001127602-19-028551 · form4.xml · nonDerivative · entry 1 Behrens Scott R. · CIK 0001616912 · VP/GM Surfactants 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 11,082.97 F1 · kind: Reflects acquisition of deferred share units under the Performance Award Deferred Compensation Plan ("Plan") pursuant to a dividend equivalent feature of the Plan. Read SEC document |
| July 30, 2019 Filed Jul 31, 2019 21:16 UTC | STEPAN CO SCL · Entity 4733 | SaleCommon Stock | 620 | $97.47 | $60,430.78 |
DisclosureSEC source: 0001127602-19-025548 · form4.xml · nonDerivative · entry 11 Behrens Scott R. · CIK 0001616912 · VP/GM Surfactants 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 11,056.913 F6 · kind: The price reported is a weighted average price. Shares were sold in a series of transactions within the same trading day at prices ranging from $97.430 to $97.540, inclusive. Full information regarding the number of shares sold at each separate price is available upon request by the Commission staff, the issuer, or a security holder of the issuer. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.